We are live on ! Find out more
CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

9 hedge funds and large institutions have $11.4M invested in Celyad Oncology SA American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

29% more funds holding

Funds holding: 7 → 9 (+2)

9% more capital invested

Capital invested by funds: $10.4M → $11.4M (+$944K)

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$460K
2
Morgan Stanley
Morgan Stanley
New York
+$156K
3
Wells Fargo
Wells Fargo
California
+$130K
4
Jane Street
Jane Street
New York
+$109K
5
UBS Group
UBS Group
Switzerland
+$21.8K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$322K
2
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
1
Victory Capital Management
Texas
$10.4M +$460K +45,778 +5%
Morgan Stanley
2
Morgan Stanley
New York
$395K +$156K +15,494 +69%
Wells Fargo
3
Wells Fargo
California
$224K +$130K +12,913 +150%
Millennium Management
4
Millennium Management
New York
$187K -$322K -32,048 -64%
Jane Street
5
Jane Street
New York
$117K +$109K +10,790 New
UBS Group
6
UBS Group
Switzerland
$32K +$21.8K +2,166 +241%
Deutsche Bank
7
Deutsche Bank
Germany
$17K +$16.9K +1,676 New
PA
8
PSI Advisors
Florida
$7K +$7.04K +700 New
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$1K – – –
Zurich Cantonal Bank
10
Zurich Cantonal Bank
Switzerland
– -$1K -100 Closed

CYAD Hedge Fund Activity: Q4 2019 in Review

9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q4 2019, worth a combined $11.4M — up 9% from $10.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CYAD positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $460K. The largest seller was Millennium Management, cutting an estimated $322K.

  • 9 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q4 2019, up from 7 in Q3 2019.
  • Funds reported $11.4M of Celyad Oncology SA American Depositary Shares stock for Q4 2019, up 9% quarter-over-quarter.
  • 3 funds opened new Celyad Oncology SA American Depositary Shares positions in Q4 2019 and 1 closed out, a net change of +2 holders.
  • The largest Celyad Oncology SA American Depositary Shares buyer in Q4 2019 was Victory Capital Management, an estimated $460K added.
  • The largest Celyad Oncology SA American Depositary Shares seller in Q4 2019 was Millennium Management, an estimated $322K sold.

Based on aggregated 13F filings for Q4 2019.